Bajaj Healthcare Limited BAJAJHCARE.NS · Stock Open Bajaj Healthcare Limited in new tab
Bajaj Healthcare Limited Analysis (BAJAJHCARE.NS)
Is Bajaj Healthcare Limited a good investment? Bajaj Healthcare Limited (BAJAJHCARE.NS) is currently trading at 322.95 INR.
In terms of valuation, the stock trades at a P/E ratio of 48.23. This high multiple suggests investors have priced in significant future growth expectations.
Earnings Schedule: Bajaj Healthcare Limited is expected to release its next earnings report on May 25, 2026.
For income investors, Bajaj Healthcare Limited pays a dividend yield of 0.45%.
Investor FAQ
Does Bajaj Healthcare Limited pay a dividend?
Yes, it pays an annual dividend of 1.50 INR (0.45% yield).
What asset class is Bajaj Healthcare Limited?
Bajaj Healthcare Limited is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be May 25, 2026. The company currently has a trailing EPS of 7.02.
Company Profile
Bajaj HealthCare Limited, a pharmaceutical company, develops, manufactures, markets, and sells active pharmaceutical ingredient, intermediates, and finished dosage forms and nutraceuticals for pharmaceutical, nutraceuticals, and food industries in India and internationally. The company offers active pharmaceutical ingredient in various therapeutic categories, including anthelmintic, anti viral, anti coagulant, vitamin c, anti arthritis, atypical antipsychotic agent, anti convulsant, vasoprotective, disinfectant, anti asthamatic, neuro protective, anti histamine, iron chelator, vasoprotective, urinary tract infection, anti migraine, anti rheumatic, antibiotic, anti tussive, weight reducing, hemorheologic agent, vasodilator, anti psychotic, beta agonist, gastroretentive drug, and antagonist. It also provides 2-amino-3,5-dibromobenzaldehyde, bromoethyl theophylline, calcium phosphoryl choline chloride, 4-hydrazinobenzoic acid and octopamine HCL, 8- chloro theophylline, chlorohexanone, theobromine, hesperidin, 5-amino-2,4,6-triiodoisophthaloyl dichloride, 3-methyl xanthine, 3-methyl-7-(2-butyn-1-yl)-8- bromo xanthine, 8 bromo-3-methyl xanthine, 4,5-dinitroaniline, 4,5-dichloro-2-nitroaniline, and 2-amino -4- hydroxyacetophenone. In addition, it offers nutraceuticals; and formulations in the form of tablets, capsules, sachets, and vials, as well as impurities. Bajaj HealthCare Limited was incorporated in 1993 and is based in Thane, India.
| Year | Total Dividends |
|---|---|
| ▸2027 |
1.50 INR
|
| Sept. 13, 2027 (estimated) | 1.5000 |
| ▸2026 |
3.06 INR
|
| Oct. 30, 2026 (estimated) | 1.5556 |
| Sept. 11, 2026 | 1.5000 |
| ▸2025 |
1.00 INR
|
| Oct. 26, 2025 | 1.0000 |
| ▸2024 |
1.00 INR
|
| Oct. 30, 2024 | 1.0000 |
| ▸2023 |
1.00 INR
|
| Oct. 30, 2023 | 1.0000 |
| ▸2022 |
1.50 INR
|
| Oct. 30, 2022 | 1.5000 |
| ▸2021 |
0.50 INR
|
| Oct. 30, 2021 | 0.5000 |
| ▸2020 |
1.75 INR
|
| Dec. 15, 2020 | 1.7500 |
| ▸2018 |
1.00 INR
|
| Oct. 28, 2018 | 1.0000 |
| Name | Payment Date | Status | Amount |
|---|---|---|---|
| Bajaj Healthcare Limited | Sep 11, 2026 | Paid | 1.5 INR |
Community Discussion